Mydecine Innovations Group
Hospitals & Physicians Clinics · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
40 King Street West Ste 5800, Toronto, O...Phone Number
(416) 595-8500Website
www.mydecine.comRevenue
<$5 MillionStock Symbol
MYCO.CNIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
2
1
1
2
2
About Mydecine Innovations Group
Mydecine offers a range of services focused on physical health, mental health, and preventive care. Their offerings include in-patient mental health services, physical therapy, and preventive care strategies aimed at enhancing overall wellness. The company targets individuals seeking holistic health solutions and support for chronic conditions. Mydecine emphasizes the importance of lifestyle choices in maintaining health and provides resources for both physical and mental well-being.Explore more
Mydecine Innovations Group Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mydecine Innovations Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Mydecine Innovations Group launches new products
Website visits: Recent activity has been detected on your website
Check out if Mydecine Innovations Group is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Mydecine Innovations Group
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Mydecine Innovations Group has new funding data
Check if Mydecine Innovations Group has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Mydecine Innovations Group recently announced quarterly report
Click to see if Mydecine Innovations Group had a recent Job posting/layoffs
Mydecine Innovations Group, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Mydecine Innovations Group as Masked Content
Find more new buyers
Compare Similar Companies to Mydecine Innovations Group
Compare insights from companies similar to Mydecine Innovations Group, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
-
2005
Company Profile Activity
Activity Insights
Mydecine Innovations Group is experiencing very low activity levels compared to other companies in the Hospitals & Physicians Clinics sector.
What does this means?
Mydecine Innovations Group is drawing exceptional interest within the Hospitals & Physicians Clinics industry, suggesting notable developments or strong market momentum, learn more about Mydecine Innovations Group.
Mydecine Innovations Group financials insights
Gather financial insights about Mydecine Innovations Group, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Share Placement
$11.8M
Mydecine Innovations Group Tech Stack
A closer look at the technologies used by Mydecine Innovations Group
Mydecine Innovations Group News & Media
Suspension of Trading
SUSPENSION OF TRADING Vancouver, British Columbia, 10 October 2024— Mydecine Innovations Group Inc. (the “Company”) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) (AQSE: MYIG) announces that its shares have been suspended from trading on the Aquis Growth Market for failure to pay exchange fees pursuant to Rule 3.10 of the Aquis Stock Exchange Rulebook (Access) with effect from today, 10/10/2024. The Directors of Mydecine take responsibility for this announcement. This announcement contains inside informatAnnual and Q1 Financial Statements
[image] MYDECINE ANNOUCES FILING OF AUDITED AND Q1 FINANCIAL STATEMENTS Vancouver, British Columbia, July 8, 2024— Mydecine Innovations Group Inc. (the “Company”) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) (AQSE: MYIG) is pleased to confirm that further to its news release dated June 14, 2024, the Company has filed on SEDAR+ its audited financial statements, accompanying management discussion and analysis and related CEO and CFO certifications for the period ended December 31, 2023 (the "Annual FilingDoc re: Bl-Weekly Status Report
MYDECINE PROVIDES Bl-WEEKLY STATUS REPORT Vancouver, British Columbia, June 14, 2024— Mydecine Innovations Group Inc. (the “Company”) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) (AQSE: MYIG) provides this update on the status of a management cease trade order granted on May 2, 2024 (the "MCTO") by the British Columbia Securities Commission under National Policy 12-203 – Management Cease Trade Order ("NP 12-203"). On May 3, 2024, the Company announced that, for reasons disclosed in the newsBl-Weekly Status Report
MYDECINE PROVIDES Bl-WEEKLY STATUS REPORT Vancouver, British Columbia, June 3, 2024— Mydecine Innovations Group Inc. (the “Company”) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) (AQSE: MYIG) provides this update on the status of a management cease trade order granted on May 2, 2024 (the "MCTO") by the British Columbia Securities Commission under National Policy 12-203 – Management Cease Trade Order ("NP 12-203"). On May 3, 2024, the Company announced that, for reasons disclosed in the news
Read more news
Top Hospitals & Physicians Clinics Companies
Frequently Asked Questions Regarding Mydecine Innovations Group
Sign Up For FreeTo access detailed company insights
Mydecine offers a range of services focused on physical health, mental health, and preventive care. Their offerings include in-patient mental health services, physical therapy, and preventive care strategies aimed at enhancing overall wellness. The company targets individuals seeking holistic health solutions and support for chronic conditions. Myd... Read More
